Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SCT200
i
Other names:
SCT200, SCT 200
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Sinocelltech
Drug class:
EGFR antagonist
Related drugs:
‹
CKD-702 (6)
CPGJ-602 (3)
rezivertinib (2)
MCLA-158 (2)
BTG-002814 (0)
cetuximab biosimilar (CDP-1) (0)
KL 140 (cetuximab biosimilar) (0)
CKD-702 (6)
CPGJ-602 (3)
rezivertinib (2)
MCLA-158 (2)
BTG-002814 (0)
cetuximab biosimilar (CDP-1) (0)
KL 140 (cetuximab biosimilar) (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
BRAF wild-type
Colorectal Cancer
BRAF wild-type
Colorectal Cancer
SCT200
Sensitive: C2 – Inclusion Criteria
SCT200
Sensitive
:
C2
SCT200
Sensitive: C2 – Inclusion Criteria
SCT200
Sensitive
:
C2
KRAS wild-type
Colorectal Cancer
KRAS wild-type
Colorectal Cancer
SCT200
Sensitive: C2 – Inclusion Criteria
SCT200
Sensitive
:
C2
SCT200
Sensitive: C2 – Inclusion Criteria
SCT200
Sensitive
:
C2
TP53 mutation
Esophageal Squamous Cell Carcinoma
TP53 mutation
Esophageal Squamous Cell Carcinoma
SCT200
Sensitive: C3 – Early Trials
SCT200
Sensitive
:
C3
SCT200
Sensitive: C3 – Early Trials
SCT200
Sensitive
:
C3
NRAS wild-type
Colorectal Cancer
NRAS wild-type
Colorectal Cancer
SCT200
Sensitive: C3 – Early Trials
SCT200
Sensitive
:
C3
SCT200
Sensitive: C3 – Early Trials
SCT200
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login